ACRS logo

Aclaris Therapeutics (ACRS)

Profile

Full Name

Aclaris Therapeutics, Inc.

Ticker Symbol

ACRS

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

October 6, 2015

Indexes

Not included

Website

http://www.aclaristx.com

Employees

61

Key Details

Price

$1.15(+6.48%)

Market cap

$124.37M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$18.72M(-40.09% YoY)

Annual EPS

-$1.71(-34.65% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.15
ACRS price is $1.15

30-Day Relative Volume

1.43
ACRS 30-day relative volume is 1.43

Price Performance

Price Most recent change

+6.48%
ACRS price was up +6.48% on Apr 11, 2025

Price YTD change

-53.63%
ACRS price is down -53.63% since January 1st

Price 1-year change

-5.74%
ACRS price is down -5.74% year-on-year

Price 3-year change

-92.77%
ACRS price is down -92.77% over the past 3 years

Price Range

Price All-time high

$33.88
ACRS price is currently -96.61% below its historical high of $33.88

Price 3-year low

$0.59
ACRS price is currently +94.92% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$124.37M
ACRS market capitalization is $124.37 million

Market cap 3-year change

-87.33%
ACRS market capitalization is down -87.33% over the past 3 years

Market cap All-time high

$1.54B
ACRS market capitalization is currently -91.93% below its historical high of $1.54 billion

Market cap sector rank

52.01%
ACRS market capitalization is higher than 52.01% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+51.79%
ACRS shares outstanding is up +51.79% year-on-year

Shares Outstanding 3-Year Change

+75.17%
ACRS shares outstanding is up +75.17% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.96
ACRS beta is 0.96

200-day SMA

$1.90
ACRS price is currently -39.62% below its 200-day simple moving average

50-day SMA

$1.85
ACRS price is currently -37.79% below its 50-day simple moving average

RSI

24.23
ACRS 14-day relative strength index is 24.23

Volume

1.43
ACRS 30-day relative volume is 1.43

ATR

$0.12
ACRS average true range is $0.12

10-day Historical Volatility

81.24%
ACRS 10-day historical volatility is 81.24%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$18.72M
ACRS annual revenue is $18.72 million

Revenue Analysts estimate

$14.38M
ACRS annual revenue is currently +30.18% higher than the consensus analysts' forecast

Revenue 1-year change

-40.09%
ACRS annual revenue is down -40.09% year-on-year

Revenue Sector rank

33.59%
ACRS annual revenue is higher than 33.59% of companies in Healthcare sector

EPS

EPS

-$1.71
ACRS annual earnings per share is -$1.71

EPS Analysts estimate

-$0.61
ACRS annual earnings per share is currently +181.48% higher than the consensus analysts' forecast

EPS 1-year change

-34.65%
ACRS annual earnings per share is down -34.65% year-on-year

EPS Sector rank

41.62%
ACRS annual earnings per share is higher than 41.62% of companies in Healthcare sector

Profit

Gross profit

$3.26M
ACRS annual gross profit is $3.26 million

Gross margin

17.43%
ACRS annual gross profit margin is 17.43%

Operating profit

-$52.53M
ACRS annual operating income is -$52.53 million

Operating margin

-280.59%
ACRS annual operating profit margin is -280.59%

Net income

-$132.06M
ACRS annual net profit is -$132.06 million

Net margin

-705.48%
ACRS annual net profit margin is -705.48%

Expenses

Total expenses

$71.25M
ACRS annual total expenses is $71.25 million

Operating expenses

$55.79M
ACRS annual total operating expenses is $55.79 million

Cost of goods sold

$15.46M
ACRS annual cost of goods sold is $15.46 million

Selling, general & administrative expenses

$22.20M
ACRS annual SGA is $22.20 million

Depreciation and amortization

$807.00K
ACRS annual depreciation & amortization is $807.00 thousand

Interest expense

-
ACRS annual interest expense value is unknown

Income tax

$0.00
ACRS annual income tax is $0.00

EBIT & EBITDA

EBIT

-$52.53M
ACRS annual earnings before interest & taxes is -$52.53 million

EBITDA

-$51.72M
ACRS annual EBITDA is -$51.72 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$220.33M
ACRS annual total assets is $220.33 million

Non current assets

$94.38M
ACRS annual long term assets is $94.38 million

Current assets

$125.95M
ACRS annual total current assets is $125.95 million

Cash and cash equivalents

$24.57M
ACRS annual cash & cash equivalents is $24.57 million

Accounts receivable

$318.00K
ACRS annual accounts receivable is $318.00 thousand

Inventory

-
ACRS annual inventory value is unknown

Liabilities

Total liabilities

$64.77M
ACRS annual total liabilities is $64.77 million

Long term liabilities

$33.18M
ACRS annual total long term liabilities is $33.18 million

Current liabilities

$31.60M
ACRS annual total current liabilities is $31.60 million

Accounts payable

$4.69M
ACRS annual accounts payable is $4.69 million

Debt

Total debt

$0.00
ACRS annual total debt is $0.00

Total debt 1-year change

0%
ACRS {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
ACRS annual long term debt value is unknown

Short term debt

-
ACRS annual short term debt value is unknown

Equity & Capital

Shareholders equity

$155.55M
ACRS annual stockholders equity is $155.55 million

Book value

$155.55M
ACRS annual book value is $155.55 million

Retained earnings

-$902.86M
ACRS annual retained earnings is -$902.86 million

Working capital

$94.36M
ACRS annual working capital is $94.36 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$20.07M
ACRS annual cash flow from operations is -$20.07 million

Cash from operations 1-year change

+74.37%
ACRS annual cash flow from operations is up +74.37% year-on-year

Cash from investing

-$69.77M
ACRS annual cash flow from investing activities is -$69.77 million

Cash from investing 1-year change

-250.95%
ACRS annual cash flow from investing activities is down -250.95% year-on-year

Cash from financing

$74.54M
ACRS annual cash flow from financing activities is $74.54 million

Cash from financing 1-year change

+179.1%
ACRS annual cash flow from financing activities is up +179.1% year-on-year

CAPEX

CAPEX

$35.93M
ACRS annual capital expenditures is $35.93 million

CAPEX 1-year change

+2644.92%
ACRS annual capital expenditures is up +2644.92% year-on-year

Free Cash Flow

Free cash flow

-$56.01M
ACRS annual free cash flow is -$56.01 million

Free cash flow 1-year change

+29.67%
ACRS annual free cash flow is up +29.67% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

17.43%
ACRS annual gross profit margin is 17.43%

Operating margin

-280.59%
ACRS annual operating profit margin is -280.59%

Net margin

-705.48%
ACRS annual net profit margin is -705.48%

ROA & ROE

ROA

-63.23%
ACRS annual return on assets is -63.23%

ROE

-84.46%
ACRS annual return on equity is -84.46%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ACRS price to earnings ratio value is unknown

PE ratio Sector rank

-
ACRS price to earnings ratio is unknown

PB Ratio

PB ratio

0.80
ACRS price to book ratio is 0.80

PB ratio Sector rank

40.05%
ACRS price to book ratio is higher than 40.05% of companies in Healthcare sector

PS Ratio

PS ratio

6.64
ACRS price to sales ratio is 6.64

PS ratio Sector rank

73.08%
ACRS price to sales ratio is higher than 73.08% of companies in Healthcare sector

Enterprise value

Enterprise value

$99.80M
ACRS enterprise value is $99.80 million

Enterprise value Sector rank

50.62%
ACRS enterprise value is higher than 50.62% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.93
ACRS EV/EBITDA is -1.93

EV/EBITDA Sector rank

32.23%
ACRS EV/EBITDA is higher than 32.23% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.99
ACRS annual current ratio is 3.99

Quick ratio

-
ACRS annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ACRS annual debt to equity ratio is 0.00

Interest coverage ratio

-
ACRS annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ACRS piotroski f-score value is unknown

Altman Z-Score

-4.77
ACRS altman z-score is -4.77

Analyst ratings

Recent major analysts updates

Mar 18, 25 Cantor Fitzgerald
Overweight
Mar 7, 25 Scotiabank
Sector Outperform
Dec 23, 24 HC Wainwright & Co.
Buy
Nov 19, 24 Leerink Partners
Outperform
Nov 19, 24 Jefferies
Buy
Nov 19, 24 BTIG
Buy
Nov 18, 24 Piper Sandler
Overweight
Sep 17, 24 HC Wainwright & Co.
Neutral
Aug 19, 24 HC Wainwright & Co.
Neutral
Jul 22, 24 HC Wainwright & Co.
Neutral

Institutional Ownership

Similar stocks

SERA logo
Sera Prognostics (SERA)
SGHT logo
Sight Sciences (SGHT)
Baird Medical Investment Holdings Limited (BDMD)
FDMT logo
4D Molecular Therapeutics (FDMT)
FATE logo
Fate Therapeutics (FATE)
SLN logo
Silence Therapeutics (SLN)
KRRO logo
Korro Bio (KRRO)
ADCT logo
ADC Therapeutics SA (ADCT)
SEER logo
Seer (SEER)
  • What is the ticker symbol for Aclaris Therapeutics?
  • Does Aclaris Therapeutics pay dividends?
  • What sector is Aclaris Therapeutics in?
  • What industry is Aclaris Therapeutics in?
  • What country is Aclaris Therapeutics based in?
  • When did Aclaris Therapeutics go public?
  • Is Aclaris Therapeutics in the S&P 500?
  • Is Aclaris Therapeutics in the NASDAQ 100?
  • Is Aclaris Therapeutics in the Dow Jones?
  • When was Aclaris Therapeutics's last earnings report?
  • When does Aclaris Therapeutics report earnings?
  • Should I buy Aclaris Therapeutics stock now?

What is the ticker symbol for Aclaris Therapeutics?

The ticker symbol for Aclaris Therapeutics is NASDAQ:ACRS

Does Aclaris Therapeutics pay dividends?

No, Aclaris Therapeutics does not pay dividends

What sector is Aclaris Therapeutics in?

Aclaris Therapeutics is in the Healthcare sector

What industry is Aclaris Therapeutics in?

Aclaris Therapeutics is in the Diagnostics & Research industry

What country is Aclaris Therapeutics based in?

Aclaris Therapeutics is headquartered in United States

When did Aclaris Therapeutics go public?

Aclaris Therapeutics's initial public offering (IPO) was on October 6, 2015

Is Aclaris Therapeutics in the S&P 500?

No, Aclaris Therapeutics is not included in the S&P 500 index

Is Aclaris Therapeutics in the NASDAQ 100?

No, Aclaris Therapeutics is not included in the NASDAQ 100 index

Is Aclaris Therapeutics in the Dow Jones?

No, Aclaris Therapeutics is not included in the Dow Jones index

When was Aclaris Therapeutics's last earnings report?

Aclaris Therapeutics's most recent earnings report was on Feb 27, 2025

When does Aclaris Therapeutics report earnings?

The next expected earnings date for Aclaris Therapeutics is May 7, 2025

Should I buy Aclaris Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page